These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31262129)

  • 1. [Outcomes of patients treated with drug-coated balloons for de novo large coronary vessels].
    Qiu J; Han ZY; Wang X; Lu WJ; Pan L; Sun GJ; Qin XF; Wang ZB; Liu GH; Wang XL; Qiu CG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jun; 47(6):452-456. PubMed ID: 31262129
    [No Abstract]   [Full Text] [Related]  

  • 2. A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.
    Yu X; Wang X; Ji F; Zhang W; Yang C; Xu F; Wang F
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):655-664. PubMed ID: 33713211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute.
    Yu X; Ji F; Xu F; Zhang W; Wang X; Lu D; Yang C; Wang F
    Clin Res Cardiol; 2019 Mar; 108(3):234-243. PubMed ID: 30074078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients.
    Funayama N; Muratsubaki S; Ito R; Tobisawa T; Konishi T
    Heart Vessels; 2023 Mar; 38(3):300-308. PubMed ID: 36045267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term outcomes from drug-coated balloon for coronary de novo lesions in large vessels.
    Lu W; Zhu Y; Han Z; Sun G; Qin X; Wang Z; Liu G; Xi W; Wang X; Pan L; Qiu C
    J Cardiol; 2019 Feb; 73(2):151-155. PubMed ID: 30366637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting Stents.
    Sim HW; Ananthakrishna R; Chan SP; Low AF; Lee CH; Chan MY; Tay EL; Loh PH; Chan KH; Tan HC; Loh JP
    J Invasive Cardiol; 2018 Jul; 30(7):256-261. PubMed ID: 29656281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Efficacy and Safety Between Drug-Coated Balloons Versus Drug-Eluting Stents in the Treatment of De Novo Coronary Lesions in Large Vessels: A Study-Level Meta-Analysis of Randomized Control Trials.
    Sun B; Zhang XT; Chen RR
    Cardiovasc Drugs Ther; 2023 Nov; ():. PubMed ID: 37999833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term outcome after treatment of de novo coronary artery lesions using three different drug coated balloons.
    Venetsanos D; Omerovic E; Sarno G; Pagonis C; Witt N; Calais F; Böhm F; Jurga J; Völz S; Koul S; Olivercrona G; James S; Alfredsson J
    Int J Cardiol; 2021 Feb; 325():30-36. PubMed ID: 32980433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 12-Month clinical results of drug-coated balloons for de novo coronary lesion in vessels exceeding 3.0 mm.
    Liu Y; Zhang YJ; Deng LX; Yin ZY; Hu T; Wang Q; Li Y; Li JY; Guo WY; Mou FJ; Tao L
    Int J Cardiovasc Imaging; 2019 Apr; 35(4):579-586. PubMed ID: 30929102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels.
    Giannini F; Latib A; Ancona MB; Costopoulos C; Ruparelia N; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):380-386. PubMed ID: 28109036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease.
    Nishiyama N; Komatsu T; Kuroyanagi T; Fujikake A; Komatsu S; Nakamura H; Yamada K; Nakahara S; Kobayashi S; Taguchi I
    Int J Cardiol; 2016 Nov; 222():113-118. PubMed ID: 27494722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Drug-Coated Balloon Approaches for
    Zhong PY; Ma Y; Shang YS; Niu Y; Bai N; Wang ZL
    Front Cardiovasc Med; 2022; 9():899701. PubMed ID: 35800174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of less drug-eluting stents by the use of drug-coated balloons in
    Wang X; Yang X; Lu W; Pan L; Han Z; Pan S; Shan Y; Wang X; Zheng X; Li R; Zhu Y; Qin P; Shi Q; Zhou S; Zhang W; Guo S; Zhang P; Qin X; Sun G; Qin Z; Huang Z; Qiu C
    Front Cardiovasc Med; 2023; 10():1045859. PubMed ID: 36937919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel completed biodegradable polymer sirolimus-eluting stent versus durable polymer sirolimus-eluting stent in de novo lesions: nine-month angiographic and three-year clinical outcomes of HOPE trial.
    Yuan F; Chen X; Song X; Wang D; Zhang Z; Li W; Li Z; Li H; Chen X; Huo Y; Wang L; Lu C; Lu Q; Xu B; Li W; Lyu S;
    Chin Med J (Engl); 2014; 127(14):2561-6. PubMed ID: 25043067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Coated Balloons: A Safe and Effective Alternative to Drug-Eluting Stents in Small Vessel Coronary Artery Disease.
    Sinaga DA; Ho HH; Watson TJ; Sim A; Nyein TT; Jafary FH; Loh JK; Ooi YW; Tan JK; Ong PJ
    J Interv Cardiol; 2016 Oct; 29(5):454-460. PubMed ID: 27578540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic efficacy of paclitaxel-coated balloon for de novo coronary lesions with diameters larger than 2.8 mm].
    Yu X; Ji FS; Xu F; Zhang WD; Wang XY; Lu D; Xu T
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):32-38. PubMed ID: 29374935
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial.
    Waksman R; Serra A; Loh JP; Malik FT; Torguson R; Stahnke S; von Strandmann RP; Rodriguez AE
    EuroIntervention; 2013 Sep; 9(5):613-9. PubMed ID: 24058077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.